Learn more

BEIJING INST CANCER RES

Overview
  • Total Patents
    52
  • GoodIP Patent Rank
    163,298
  • Filing trend
    ⇩ 100.0%
About

BEIJING INST CANCER RES has a total of 52 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are STICHTING VUMC, LEAP THERAPEUTICS INC and BEIJING INSTITUTE FOR CANCER RES.

Patent filings per year

Chart showing BEIJING INST CANCER RESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Deng Dajun 11
#2 Shou Chengchao 10
#3 Zhou Jing 8
#4 Liu Zhaojun 5
#5 Meng Lin 5
#6 Chengchao Shou 5
#7 Han Haibo 4
#8 Xing Baocai 4
#9 Jian Wu 4
#10 Zhao Wei 4

Latest patents

Publication Filing date Title
CN106916788A People taxol resistance stomach cancer cell HGC 27/PTX and preparation method thereof
CN106692247A Application of Taraxacum mongolicum extract in preparation of anticancer drugs
CN106479891A Colorectal cancer primitive cell culture kit and its application process
CN106308927A Multi-tip extension type radiofrequency ablation electrode needle
CN106902394A Thermo-sensitive material protects the application of internal organs surrounding structure parenteral solution in heating ablation is prepared
CN105085648A Corresponding antigen of anti-ovarian cancer monoclonal antibody COC166-9 and application thereof
CN104138598A Method and preparation for preventing mycoplasma hyorhinis from infecting cells
CN103877662A Hepatic artery medicine box retention catheter system
CN103815953A Real-time three-dimensional visual image-guided system for puncture
CN103571933A Premier pair and kit for detecting expression state of MT2A in cancer cells, and application of DATS in expression of MT2A
CN102590511A Tumor diagnosis reagent or kit based on detection of IGFBP-2 (insulin-like growth factor binding protein 2) autoantibody or combined detection of IGFBP-2 antoantibody and IGFBP-2, as well as application thereof
WO2013120222A1 Method for in vitro estimation of tumorigenesis, metastasis, or life expectancy and artificial nucleotide used
CN102344962A Serum miR-21 (micro-ribonucleic acid-21) detection kit based on luorescence quantitative PCR (polymerase chain reaction) and application thereof
CN102805829A Preparation method of rhizoma smilacis glabrae extract and applications thereof in tumor treatment
CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof
CN102181401A Survivin enzyme-linked immunoassay kit and application thereof
WO2012097477A1 Methods and nucleotides for assessing tumor metastasis or prognosis in vitro
EP2664675A1 Primer group for detecting cpg island methylation of p16 gene using methylation-specific fluorescence technique
CN102532317A Monoclonal antibody of PES1 and application thereof
WO2012009828A1 Chemical modification method and detection method of 5-hydroxymethylcytosine in dna molecules